Thrombocythemia
Showing 101 - 125 of 328
Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Rochester (CC-4047)
Completed
- Chronic Myeloproliferative Disorders
- Secondary Myelofibrosis
-
Rochester, MinnesotaMayo Clinic
Dec 16, 2019
Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)
Completed
- Primary Myelofibrosis
- +9 more
-
Camperdown, New South Wales, Australia
- +17 more
Apr 3, 2020
Thrombosis in Myeloproliferative Neoplasms
Completed
- Myeloproliferative Neoplasm
- 2 additional tubes of blood
-
Angers, France
- +23 more
Aug 17, 2022
Philadelphia Negative Myeloproliferative Tumors Trial
Not yet recruiting
- Philadelphia Negative Myeloproliferative Neoplasms
- (no location specified)
Jun 5, 2022
Hepatomegaly, Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis
Terminated
- Hepatomegaly
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 23, 2019
Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)
Recruiting
- Myeloproliferative Neoplasms
-
Herston, Queensland, Australia
- +22 more
Jun 30, 2023
Hematological Disorder in Patients With Angiodysplasia
Not yet recruiting
- Angiodysplasia
- Hematological Disease
- Von willebrand antigen
- (no location specified)
Sep 26, 2023
Myeloproliferative Neoplasia With Normal CBC and Thrombotic
Recruiting
- Thrombotic Patients
- +2 more
-
Nantes, Loire-Atlantique, FranceNantes University Hospital
Sep 8, 2021
Assess Real-World Patient-Reported Outcomes With Fedratinib for
Recruiting
- Myelofibrosis
-
City, State, AustriaLocal Institution
Dec 16, 2022
Myeloproliferative Tumors Trial in Canada, Spain, United States (VAC85135, Ipilimumab)
Recruiting
- Myeloproliferative Neoplasms
- VAC85135
- Ipilimumab
-
Birmingham, Alabama
- +16 more
Jan 27, 2023
Primary Myelofibrosis (MF), Post-Polycythemia Vera (PV) MF, Post-Essential Thrombocythemia (ET) MF Trial in Worldwide
Completed
- Primary Myelofibrosis (MF)
- +2 more
-
Beijing, Beijing, China
- +25 more
Aug 29, 2019
Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary
Withdrawn
- Myelofibrosis Transformation in Essential Thrombocythemia
- +2 more
- LOXL2 Inhibitor PAT-1251
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2019
Chronic Myeloproliferative Tumors Trial in Germany, Italy, United Kingdom (givinostat)
Active, not recruiting
- Chronic Myeloproliferative Neoplasms
-
Berlin, Germany
- +14 more
Jun 14, 2021
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in
Completed
- Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
- +13 more
- Cyclosporine
- +6 more
-
Salt Lake City, Utah
- +2 more
Jan 15, 2020
Polycythemia Vera, Thrombocythemia Trial in Houston (CC-4047, Prednisone)
Completed
- Polycythemia Vera
- Thrombocythemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 5, 2019
Research Tissue Bank
Completed
- Myelofibrosis
- +3 more
-
Palo Alto, California
- +10 more
Jul 2, 2019
Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))
Not yet recruiting
- Polycythemia Vera
- Ropeginterferon alfa-2b-njft (P1101)
- (no location specified)
Jul 28, 2022
Polycythemia Trial (CO-Rebreathing technique at diagnosis of polycythemia)
Completed
- Polycythemia
- CO-Rebreathing technique at diagnosis of polycythemia
-
Amiens, Picardie, FranceCHU Amiens Picardie
Jan 17, 2023
Epigenetic Age on Clinic-biological Presentation and Prognosis
Not yet recruiting
- Myeloproliferative Neoplasm
- Assessment of the epigenetic age
-
Bordeaux, FranceCHU de Bordeaux, service Hématologie Biologique
Aug 28, 2023
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States
Completed
- Primary Myelofibrosis
- +2 more
-
Highland, California
- +20 more
Mar 18, 2019